Assenagon Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-347,961
| Closed | -$31.6M | – | 1458 |
|
|
2023
Q1 | $31.6M | Buy |
+347,961
| New | +$31.6M | 0.11% | 148 |
|
|
2022
Q1 | – | Sell |
-172,323
| Closed | -$4.54M | – | 1538 |
|
|
2021
Q4 | $4.54M | Buy |
+172,323
| New | +$4.54M | 0.01% | 514 |
|
|
2020
Q2 | – | Sell |
-31,463
| Closed | -$4.54M | – | 1233 |
|
|
2020
Q1 | $4.54M | Sell |
31,463
-5,842
| -16% | -$843K | 0.04% | 213 |
|
|
2019
Q4 | $7.63M | Buy |
+37,305
| New | +$7.63M | 0.05% | 168 |
|